Market Research: Global Lung Cancer Therapeutics Market to contribute around $11.19 billion during the period 2017-2020
ResearchMoz presents professional and in-depth study of “Global Lung Cancer Therapeutics Market 2016-2020”.
Published June 13, 2017 Medgadget, LLC. 2004-2016.
All rights reserved. The Medical Revolution Will Be Blogged
ResearchMoz presents professional and in-depth study of “Global Lung Cancer Therapeutics Market 2016-2020”.
Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes almost 85%-90% of the total diagnosed cases. It grows and spreads quite slowly.
Technavios analysts forecast the global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global lung cancer therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent lung cancer therapeutics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
- Americas – North and South America
- APAC – Asia Pacific Region
- EMEA – Europe, the Middle East and Africa
Get PDF for more Professional and Technical insights here.
Technavio’s report, Global Lung Cancer Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.